$14.44
0.090.63%
In chiusura: -
$13.54
-0.90-6.24%
After hour: 4:53 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Theravance Biopharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-0.080
Stima dei ricavi trimestrali
$19.77M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$77.20M
Analizza lo storico degli utili di Theravance Biopharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TBPH | Theravance Biopharma | -$0.06 | -$0.08 | — | — | $16.87M | $19.77M | — | — | 11/11/2025 | |
TBPH | Theravance Biopharma | -$0.13 | -$0.17 | -$0.08 | 52.94% | $14.26M | $22.44M | $26.20M | 16.75% | 08/12/2025 | |
TBPH | Theravance Biopharma | -$0.09 | -$0.09 | -$0.27 | -200.00% | $14.50M | $28.07M | $15.39M | -45.18% | 05/08/2025 | |
TBPH | Theravance Biopharma | -$0.17 | -$0.08 | -$0.05 | 37.50% | $17.57M | $17.09M | $18.75M | 9.74% | 02/26/2025 | |
TBPH | Theravance Biopharma | -$0.17 | -$0.23 | -$0.06 | 73.91% | $15.69M | $15.34M | $16.87M | 9.96% | 11/12/2024 | |
TBPH | Theravance Biopharma | -$0.13 | -$0.21 | -$0.13 | 38.10% | $13.75M | $15.45M | $14.26M | -7.73% | 08/05/2024 | |
TBPH | Theravance Biopharma | -$0.24 | -$0.25 | -$0.09 | 64.00% | $10.42M | $13.96M | $14.50M | 3.89% | 05/13/2024 | |
TBPH | Theravance Biopharma | -$0.15 | -$0.15 | -$0.17 | -13.33% | $14.65M | $17.68M | $17.57M | -0.65% | 02/26/2024 | |
TBPH | Theravance Biopharma | -$0.21 | -$0.21 | -$0.17 | 19.05% | $12.45M | $15.00M | $15.69M | 4.62% | 11/07/2023 | |
TBPH | Theravance Biopharma | -$0.04 | -$0.16 | -$0.13 | 18.75% | $11.05M | $15.24M | $13.75M | -9.78% | 08/07/2023 | |
TBPH | Theravance Biopharma | -$0.33 | -$0.26 | -$0.24 | 7.69% | $13.20M | $13.84M | $10.42M | -24.73% | 05/08/2023 | |
TBPH | Theravance Biopharma | -$0.18 | -$0.17 | -$0.21 | -23.53% | $14.95M | $15.73M | $14.65M | -6.87% | 02/27/2023 | |
TBPH | Theravance Biopharma | -$0.46 | -$0.18 | -$0.21 | -16.67% | $13.19M | $12.05M | $12.45M | 3.33% | 11/07/2022 | |
TBPH | Theravance Biopharma | -$0.80 | -$0.03 | -$0.04 | -33.33% | $12.91M | $12.41M | $11.05M | -10.96% | 08/04/2022 | |
TBPH | Theravance Biopharma | -$1.24 | -$0.11 | -$0.22 | -100.00% | $14.26M | $14.48M | $13.20M | -8.87% | 05/05/2022 | |
TBPH | Theravance Biopharma | -$0.92 | -$0.33 | -$0.18 | 45.45% | $18.73M | $13.48M | $14.95M | 10.87% | 02/23/2022 | |
TBPH | Theravance Biopharma | -$1.16 | -$0.55 | -$0.46 | 16.36% | $18.26M | $14.69M | $13.19M | -10.18% | 11/03/2021 | |
TBPH | Theravance Biopharma | -$1.00 | -$1.01 | -$0.80 | 20.79% | $15.01M | $15.41M | $12.91M | -16.20% | 08/03/2021 | |
TBPH | Theravance Biopharma | -$1.14 | -$1.05 | -$1.24 | -18.10% | $19.86M | $17.27M | $14.26M | -17.45% | 05/04/2021 | |
TBPH | Theravance Biopharma | -$1.17 | -$1.02 | -$0.92 | 9.80% | $29.50M | $20.85M | $18.73M | -10.17% | 02/23/2021 | |
TBPH | Theravance Biopharma | -$1.05 | -$0.97 | -$1.16 | -19.59% | $12.43M | $18.58M | $18.26M | -1.74% | 11/05/2020 |
Theravance Biopharma (TBPH) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.08 | $-0.17 | 52.9 % |
| Q1 | 2025-05-08 | $-0.27 | $-0.09 | -200.0 % |
| Q4 | 2025-02-26 | $-0.05 | $-0.08 | 37.5 % |
| Q3 | 2024-11-12 | $-0.06 | $-0.23 | 73.9 % |
Theravance Biopharma (TBPH) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $26.20M | $22.44M | 16.8 % |
| Q1 | 2025-05-08 | $15.39M | $28.07M | -45.2 % |
| Q4 | 2025-02-26 | $18.75M | $17.09M | 9.74 % |
| Q3 | 2024-11-12 | $16.87M | $15.34M | 9.96 % |
FAQ
Quando Theravance Biopharma (NASDAQ:TBPH) riporterà gli utili?
Si prevede che Theravance Biopharma (TBPH) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Theravance Biopharma (NASDAQ:TBPH)?
L'EPS effettivo era $-0.08, che superato la stima di $-0.17.
Quali sono state le entrate di Theravance Biopharma (NASDAQ:TBPH)?
Le entrate effettive sono state $26.2M, che superato la stima di $22.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.